ARQT vs UBER · rev $196.5M vs P/E 18, rev $52.02B
Arcutis Biotherapeutics Inc (ARQT) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported ARQT revenue for 2024-12-31 was $196.5M. Net income was -$140.0M. Revenue was up 229.7% from 2023-12-31 to 2024-12-31. ARQT currently screens at market cap $1.64B.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
ARQT currently screens at market cap $1.64B. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the ARQT and UBER stock pages for the full models.
Not investment advice.